Budefort Inhalation Capsule 100 mcg+6 mcg is a low-dose combination inhalation therapy containing Budesonide and Formoterol Fumarate, designed for the long-term management of asthma and chronic obstructive pulmonary disease (COPD). By combining an inhaled corticosteroid with a long-acting beta₂-adrenergic agonist, Budefort provides both anti-inflammatory action and sustained bronchodilation, making it effective for patients requiring milder maintenance therapy while minimizing potential side effects.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Composition

Each inhalation capsule contains:

• Budesonide 100 mcg

• Formoterol Fumarate 6 mcg

Therapeutic Class

• Inhaled corticosteroid (ICS)

• Long-acting beta₂-adrenergic agonist (LABA)

• Bronchodilator and anti-inflammatory agent

Pharmacology and Mechanism of Action

Budesonide is a corticosteroid that reduces airway inflammation by inhibiting inflammatory mediators, decreasing swelling, mucus secretion, and bronchial hyperresponsiveness. This helps prevent asthma attacks and reduces the risk of COPD exacerbations.

Formoterol Fumarate is a selective long-acting beta₂-adrenergic receptor agonist. It relaxes the bronchial smooth muscle to provide sustained bronchodilation and improve airflow. Formoterol has a rapid onset of action, offering prompt symptom relief while maintaining long-term airway control.

The combination of budesonide and formoterol provides a dual therapeutic effect: anti-inflammatory protection from budesonide and airway relaxation from formoterol. This synergistic action is particularly suitable for patients with mild to moderate asthma or COPD who require lower-dose maintenance therapy.

Indications

Budefort Inhalation Capsule 100 mcg+6 mcg is indicated for:

• Long-term maintenance treatment of asthma in adults and adolescents

• Management of mild to moderate COPD

• Prevention of asthma or COPD exacerbations

• Improvement of breathing, lung function, and overall quality of life in patients with chronic respiratory symptoms

Note: This inhalation capsule is not intended for acute relief of sudden bronchospasm.

Dosage and Administration

Budefort Inhalation Capsule is for inhalation use only with a compatible dry powder inhaler device. The usual recommended dose is one capsule inhaled twice daily, or as directed by a healthcare professional. Correct inhalation technique is essential for effective delivery of the medication to the lungs.

Patients should rinse their mouth after inhalation to reduce the risk of oral candidiasis and maintain oral hygiene.

Benefits

• Provides sustained bronchodilation for improved airflow

• Reduces airway inflammation and prevents exacerbations

• Suitable for patients requiring low-dose maintenance therapy

• Convenient twice-daily dosing enhances adherence

• Improves symptom control, exercise tolerance, and overall quality of life

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Not suitable for acute asthma or COPD attacks

• Use with caution in patients with cardiovascular conditions, infections, or hypersensitivity

• Rinse mouth after use to prevent oral thrush

• Avoid exceeding the prescribed dosage

• Use during pregnancy and breastfeeding only under medical supervision

Storage

Store below 30°C in a dry place. Protect from light and moisture. Keep out of reach of children.